To amend title XVIII of the Social Security Act to require certain reporting with respect to agents and brokers of Medicare Advantage organizations.
Summary
HR9395 is an early-stage bill requiring Medicare Advantage organizations to report on agent/broker activities. It carries no funding and has only been referred to committee. Its market impact is negligible — compliance costs for major insurers like UnitedHealthcare are de minimis relative to revenue.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR9395 is a low-impact, early-stage procedural bill targeting MA broker reporting.
- 2.No funding is authorized — the effect is purely regulatory compliance.
- 3.For UnitedHealthcare and other MA insurers, cost impact is immaterial (<0.5% of revenue).
Market Implications
No actionable market implications. The bill does not change MA payment rates, star ratings, or regulatory structure in a material way. Insurers' MA margins remain driven by CMS reimbursement benchmarks and utilization trends, not broker reporting.
Full Analysis
On June 23, 2026, Rep. Alexandria Ocasio-Cortez introduced HR9395 in the 119th Congress. The bill amends Title XVIII of the Social Security Act to impose reporting requirements on agents and brokers of Medicare Advantage (MA) organizations. It was referred to both the Ways and Means and Energy and Commerce Committees — standard for Medicare-related legislation. This is a very early stage; no committee hearings or votes have occurred. The bill authorizes no funding; it is a regulatory measure. For a major MA carrier like UnitedHealthcare (UNH), with ~$400B annual revenue, incremental compliance costs are trivial — likely under $200M annually if fully implemented. Other MA insurers (e.g., Humana, CVS/Aetna) could be similarly affected but the impact remains minor. Congress's agenda is crowded and this bill faces an uncertain path. No convergence with other signals was identified in the provided data.
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
No confirming evidence found yet from contracts, insider trades, or congressional activity
What the bill does
Required reporting on agents/brokers of Medicare Advantage organizations
Who must act
Medicare Advantage organizations (e.g., UnitedHealthcare's Medicare Advantage plans) and their agents/brokers
What happens
Increased compliance and reporting costs, potential reduction in broker commissions or agent network size
Stock impact
UnitedHealthcare (UNH) operates large Medicare Advantage plans under its UnitedHealthcare segment. Reporting requirements raise administrative expenses modestly; broker commissions may be constrained, marginally affecting enrollment growth. Likely <0.5% of UNH's ~$400B revenue, minimal earnings impact.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services of the Department of Health and Human Services relating to "Medicare Program; Implementation of Prior Authorization for Select Services for the Wasteful and Inappropriate Services Reduction (WISeR) Model".
January 6th Law Enforcement Heroes Compensation Fund Act
Mental Health Access and Provider Support Act of 2026
Improving Seniors’ Timely Access to Care Act of 2025
To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to require health insurance issuers and MA organizations to make publicly available certain information with respect to coverage request rejection.
PBM Act
Great American Healthcare Plan
Review Every Veteran’s Claim Act of 2025
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Continuing to Protect the Meaning and Value of American Citizenship
This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.
Ending Birth Tourism
This executive order directs the Secretaries of State and Homeland Security to prevent foreign nationals from entering the U.S. on nonimmigrant visas for the purpose of giving birth (birth tourism), including revoking visas, barring entry, and taking action against facilitators. It defines birth tourism as entry via nonimmigrant visa for childbirth and allows humanitarian or national interest exemptions.
Adjusting Imports of Polysilicon and its Derivatives into the United States
This proclamation invokes Section 232 of the Trade Expansion Act to impose a minimum import price (MIP) program on polysilicon and its derivatives, a 15% ad valorem tariff on polysilicon derivatives, and directs the Secretary of Commerce to offer incentives for domestic production. It aims to protect and revive the U.S. polysilicon industry by restricting imports that threaten national security, particularly for semiconductor and solar supply chains.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →